Predicting the Persistence of Insomnia Symptoms during the COVID-19 Pandemic.

IF 2.2 3区医学 Q3 CLINICAL NEUROLOGY

Behavioral Sleep Medicine Pub Date : 2024-07-01 Epub Date: 2023-12-26 DOI:10.1080/15402002.2023.2298377

Zachary Ta, Allyson A Gilles, Nasim Parsinejad, Marlene J Egger, Kelly Glazer Baron

{"title":"Predicting the Persistence of Insomnia Symptoms during the COVID-19 Pandemic.","authors":"Zachary Ta, Allyson A Gilles, Nasim Parsinejad, Marlene J Egger, Kelly Glazer Baron","doi":"10.1080/15402002.2023.2298377","DOIUrl":null,"url":null,"abstract":"Objective: The goal of this study is to evaluate the factors associated with vulnerability and course of insomnia longitudinally in the COVID-19 pandemic and examine differences between: (a) those who never demonstrated clinical insomnia symptoms, (b) those who demonstrated clinically elevated insomnia symptoms at 1 or 2 time points, and (c) those who demonstrated clinically elevated insomnia symptoms at all 3 time points.Methods: Participants (≥18 years old) completed measures of insomnia (ISI), depression (PHQ-8), anxiety (GAD-7), and pre-sleep arousal (PSAS) at 3 time points (baseline, 1 month, and 3 months). Data were analyzed using univariable odds ratios and multivariable multicategory logistic regression to determine demographic, psychological, and behavioral predictors of insomnia persistence.Results: A total of 129 participants completed all 3 assessments (70 female, age M = 44 years, SD = 16). We found that 40% (N = 51) never had insomnia symptoms, 33% (N = 42) reported transient insomnia symptoms (1 or 2 time points), and 28% (N = 36) reported persistent insomnia symptoms (all 3 time points). From the multivariable multicategory logistic analyses, pre-sleep arousal, gender, and income were significant predictors of insomnia persistence.Conclusions: Findings indicate elevated insomnia symptoms were persistent in a substantial number of individuals throughout the pandemic. Results suggest additional insomnia and psychological interventions are needed to improve sleep and mental health.","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"433-445"},"PeriodicalIF":2.2000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioral Sleep Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15402002.2023.2298377","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The goal of this study is to evaluate the factors associated with vulnerability and course of insomnia longitudinally in the COVID-19 pandemic and examine differences between: (a) those who never demonstrated clinical insomnia symptoms, (b) those who demonstrated clinically elevated insomnia symptoms at 1 or 2 time points, and (c) those who demonstrated clinically elevated insomnia symptoms at all 3 time points.

Methods: Participants (≥18 years old) completed measures of insomnia (ISI), depression (PHQ-8), anxiety (GAD-7), and pre-sleep arousal (PSAS) at 3 time points (baseline, 1 month, and 3 months). Data were analyzed using univariable odds ratios and multivariable multicategory logistic regression to determine demographic, psychological, and behavioral predictors of insomnia persistence.

Results: A total of 129 participants completed all 3 assessments (70 female, age M = 44 years, SD = 16). We found that 40% (N = 51) never had insomnia symptoms, 33% (N = 42) reported transient insomnia symptoms (1 or 2 time points), and 28% (N = 36) reported persistent insomnia symptoms (all 3 time points). From the multivariable multicategory logistic analyses, pre-sleep arousal, gender, and income were significant predictors of insomnia persistence.

Conclusions: Findings indicate elevated insomnia symptoms were persistent in a substantial number of individuals throughout the pandemic. Results suggest additional insomnia and psychological interventions are needed to improve sleep and mental health.

查看原文本刊更多论文

预测 COVID-19 大流行期间失眠症状的持续性。

研究目的本研究旨在纵向评估 COVID-19 大流行中与失眠症易感性和病程相关的因素，并研究以下人群之间的差异：(a) 从未出现临床失眠症状的人群；(b) 在 1 个或 2 个时间点出现临床失眠症状加重的人群；(c) 在所有 3 个时间点出现临床失眠症状加重的人群：参与者（≥18 岁）在 3 个时间点（基线、1 个月和 3 个月）完成失眠（ISI）、抑郁（PHQ-8）、焦虑（GAD-7）和睡前唤醒（PSAS）的测量。通过单变量几率比和多变量多类别逻辑回归对数据进行分析，以确定失眠持续性的人口、心理和行为预测因素：共有 129 名参与者完成了所有 3 项评估（70 名女性，年龄 M = 44 岁，SD = 16）。我们发现，40%（N = 51）的人从未有过失眠症状，33%（N = 42）的人报告了短暂失眠症状（1 或 2 个时间点），28%（N = 36）的人报告了持续失眠症状（所有 3 个时间点）。在多变量多类别逻辑分析中，睡前唤醒、性别和收入是持续失眠的重要预测因素：研究结果表明，在整个大流行期间，相当多的人持续出现失眠症状。结果表明，需要采取更多失眠和心理干预措施来改善睡眠和心理健康。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Behavioral Sleep Medicine CLINICAL NEUROLOGY-PSYCHIATRY

CiteScore

7.20

自引率

3.20%

发文量

审稿时长

>12 weeks

期刊介绍： Behavioral Sleep Medicine addresses behavioral dimensions of normal and abnormal sleep mechanisms and the prevention, assessment, and treatment of sleep disorders and associated behavioral and emotional problems. Standards for interventions acceptable to this journal are guided by established principles of behavior change. Intending to serve as the intellectual home for the application of behavioral/cognitive science to the study of normal and disordered sleep, the journal paints a broad stroke across the behavioral sleep medicine landscape. Its content includes scholarly investigation of such areas as normal sleep experience, insomnia, the relation of daytime functioning to sleep, parasomnias, circadian rhythm disorders, treatment adherence, pediatrics, and geriatrics. Multidisciplinary approaches are particularly welcome. The journal’ domain encompasses human basic, applied, and clinical outcome research. Behavioral Sleep Medicine also embraces methodological diversity, spanning innovative case studies, quasi-experimentation, randomized trials, epidemiology, and critical reviews.